维普中文期刊产品整合服务
327篇 您的检索式:作者名="Sivridis"
    题名 作者 年代 出处 被引量
1Thermogenic protein UCP1 and UCP3 expression in non- small cell lung cancer: relation with glycolysis and anaerobic metabolism显示文摘Uncoupling protein 1(UCP1)is a proton transporter/channel residing on the inner mitochondrial membrane and is involved in cellular heat production.Using immunohistochemistry,we investigated the expression of UCP1 and UCP3 in a series of 98 patients with non-small cell lung cancer(NSCLC)treated with surgery.Expression patterns were correlated with histopathological variables,prognosis,and the expression of enzymes/proteins related to cell metabolism.Bronchial epithelium did not express UCP1 or UCP3,while alveolar cells strongly expressed UCP1.In tumors,strong expression of UCP1 and UCP3 was recorded in43/98(43.8%)and 27/98(27.6%)cases,respectively.UCP1 was significantly associated with squamous cell histology(P=0.05),whilst UCP3 was more frequently overexpressed in large cell carcinomas(P=0.08),and was inversely related to necrosis(P=0.009).In linear regression analysis,UCP1 was directly related to markers of glycolysis[hexokinase(HXKII)and phosphofructokinase(PFK1)]and anaerobic glucose metabolism[pyruvate dehydrogenase kinase(PDK1)and lactate dehydrogenase(LDH5)].UCP3 was directly linked with a glucose transporter(GLUT2),monocarboxylate transporter(MCT2),glycolysis markers(PFK1 and aldolase),and with the phosphorylation of pyruvate dehydrogenase(p PDH).Kaplan-Meier survival analysis showed that UCP3 was significantly related to poor prognosis in squamous cell carcinomas(P=0.04).UCP1 and UCP3 are overexpressed in a large subgroup of non-small cell lung tumors and their expression coincides with increased glucose absorption,intensified glycolysis,and anaerobic glucose usage.Whether UCPs are targets for therapeutic interventions in lung cancer is a hypothesis that demands further investigation.Alexandra Giatromanolaki Konstantina Balaska Dimitra Kalamida Christos Kakouratos Efthimios Sivridis Michael I. Koukourakis 2017Cancer Biology & Medicine2017,14,4:8
2Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin显示文摘Karpouzis A Giatromanolaki A Sivridis E 2003Eur J Dermatol2003,13,2:2
3Lac- tate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vas- cular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group 显示文摘Koukourakis MI Giatromanolaki A Sivridis E 2006J Clin Oncol2006,24,26:1
4Hypoxia-inducible factor ( HIF1A and HIF2A), angiogenesis, and chemoradiotherapy out- come of squamous cell head-and-neck cancer显示文摘Koukourakis MI Giatromanolaki A Sivridis E 2002Int J Radiat Oncol Biol Phys2002,53,5:1
5Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression显示文摘Efthimios Sivridis Alexandra Giatromanolaki Michael Koukourakis Panagiotis Anastasiadis 2001Virchows Archiv2001,,5:1
6Upregulated hypoxia inducible factor-lalpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis显示文摘Giatromanolaki A Sivridis E Maltezos E 2003Arthritis Res Ther2003,5,4:1
7Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angio- genic/molecular profile of tumours and survival 显示文摘Giatromanolaki A Koukourakis MI Sivridis E 2001Br J Cancer2001,85,6:1
8Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma 显示文摘Koukourakis M I Giatromanolaki A Sivridis E 2005Neoplasia2005,7,1:1
9Asso- ciation of hypoxia-inducible factors lalpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma 显示文摘Sivridis E Giatromanolaki A Gatter K C 2002Cancer2002,95,5:1
10The angiogenic 'vascular endothelial growth factor/flk-1 (KDR)receptor'pathway in patients with endometrial carcinoma 显示文摘 Sivridis E Brekken R 2001Cancer2001,92,10:1
11Lactate de- hydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF,/VEGFR2 (KDR) pathway and prognosis显示文摘Giatromanolaki A Sivridis E Gatter KC 2006Gynecol Oncol2006,103,3:1
12Angiogenesis in colorectal cancer: prognostic and therapeutic implications 显示文摘Giatromanolaki A Sivridis E Koukourakis MI 2006Am J Clin Oncol2006,29,4:1
13LYVE-1 immunohistochemical assessment of lymphangiogenesis in endome- trial and lung cancer显示文摘Koukourakis M I Giatromanolaki A Sivridis E 2005J Clin Pathol2005,58,2:1
14Angiogenic Factor Expression in Hepatic Cirrhosis显示文摘Alexandra Giatromanolaki Stamatia Kotsiou Michael I. Koukourakis Efthimios Sivridis 2007Mediators of Inflammation2007,,:1
15LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer显示文摘Koukourakis MI Giatromanolaki A Sivridis E 2005J Clin Pathol2005,58,:1
16Hypoxia-inducible factor(HIF1A and HIF2A),angiogenesis,and chemoradiotherapy outcome of squamous cell head and neck cancer显示文摘Koukourakis MI Giatromanolaki A Sivridis E 2002Int J Radiat Oncol Biol Phys2002,53,5:1
17Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas显示文摘Giatromanolaki A Sivridis E Simopoulos C 2006J Surg Oncol2006,94,3:1
18Hypoxia-regula- ted carbonic anhydrase-9 ( CA9 ) relates to poor vascularization and re- sistance of squamous cell head and neck cancer to chemoradiotherapy 显示文摘Koukourakis MI Giatromanolaki A Sivridis E 2001Clin Cancer Res2001,7,11:1
19Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival显示文摘Giatromanolaki A Koukourakis MI Sivridis E 2001Br J Cancer2001,85,6:1
20Loss of expres- sion and nuclear/cytoplasmic localization of the FOXP1 forkhead tra- nscription factor are common events in early endometrial cancer: rel-ationship with estrogen receptors and HIF-1 ct expression 显示文摘Giatromanolaki A Koukourakis MI Sivridis E 2005Modem Pathol2005,19,1:1
返回顶部 每页显示:
共17页 首页 上一页 第1页 下一页 末页 /17 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费